Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Interventions: GENETIC: n/a - observational
Sponsor: Institute of Cancer Research, United Kingdom